Medicare Enrolled

Dr. James Turner, M.D.

Internal Medicine · Clifton, NJ
Low-engagement
842 CLIFTON AVE, Clifton, NJ 07013
9734723331
In practice since 2007 (18 years)
NPI: 1245424159 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Turner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Turner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Turner

Dr. James Turner is an internal medicine specialist in Clifton, NJ, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Turner received a total of $6,660 from 30 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Turner is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $6,660 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$6,660
Total received (2018-2022)
Avg $1,332/year across 5 years
Top 12% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,660 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$96
2021
$2,194
2020
$1,527
2019
$2,502
2018
$341

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Chiesi USA, Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
AstraZeneca Pharmaceuticals LP
$1,156
GlaxoSmithKline, LLC.
$914
Janssen Pharmaceuticals, Inc
$768
Boston Scientific Corporation
$620
MannKind Corporation
$401
Novo Nordisk Inc
$291
Amarin Pharma Inc.
$286
Boehringer Ingelheim Pharmaceuticals, Inc.
$269
Neurocrine Biosciences, Inc.
$262
AbbVie, Inc.
$241
Lilly USA, LLC
$149
AbbVie Inc.
$139
Alexion Pharmaceuticals, Inc.
$133
Novartis Pharmaceuticals Corporation
$125
Mannkind Corporation
$124
Sunovion Pharmaceuticals Inc.
$117
ARBOR PHARMACEUTICALS, INC.
$110
ABIOMED
$100
Teva Pharmaceuticals USA, Inc.
$88
Chiesi USA, Inc.
$81
Amgen Inc.
$70
Avanir Pharmaceuticals, Inc.
$45
Horizon Pharma plc
$31
Merck Sharp & Dohme Corporation
$30
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
Kowa Pharmaceuticals America, Inc.
$28
Nabriva Therapeutics, plc
$14
PFIZER INC.
$13
Astellas Pharma US Inc
$12
Abbott Laboratories
$12
Top 3 companies account for 42.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · Aimovig · Andexxa · BREZTRI · CHANTIX · CLEVIPREX · CREON · Creon · ENTRESTO · EVENITY · Edarbi · FARXIGA · FreeStyle Libre 2 · INGREZZA · INVOKANA · Impella · JANUVIA · JARDIANCE · KRYSTEXXA · Livalo · MOVIPREP · MYRBETRIQ · NUEDEXTA · Ozempic · RYBELSUS · Repatha · TRELEGY ELLIPTA · TRULICITY · Tresiba · UTIBRON · Vascepa · Victoza · WATCHMAN · XARELTO · XIFAXAN · Xenleta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Clifton?
Compare internal medicine physicians in the Clifton area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
10,309
Per 100K population
1989.0
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
2.2 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Turner is an internal medicine specialist, with low-engagement industry engagement in the top 12% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Turner receive payments from pharmaceutical companies?
Yes. Dr. Turner received a total of $6,660 from 30 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Turner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Internal Medicine Physicians in Clifton
Browse internal medicine physicians in Clifton ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →